Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_053938157.1 WG78_RS12490 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_001294205.1:WP_053938157.1 Length = 408 Score = 446 bits (1147), Expect = e-130 Identities = 245/394 (62%), Positives = 288/394 (73%), Gaps = 10/394 (2%) Query: 4 LGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINMLD 63 +GT L +AT+VMLLGSGELGKEV I QRLGVEVIAVDRYADAP M VAHRSHVINM D Sbjct: 7 IGTPLSASATKVMLLGSGELGKEVIIALQRLGVEVIAVDRYADAPGMQVAHRSHVINMAD 66 Query: 64 GDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGL-NVVPCARATKLTMNREGIRRLAA 122 ALR +VE EKPH IVPEIEAIAT+ L+++E + + V+P ARAT LTMNREGIRRLAA Sbjct: 67 PVALRALVEQEKPHLIVPEIEAIATEELLRIEADKVAEVIPTARATNLTMNREGIRRLAA 126 Query: 123 EELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQ 182 E L L TS Y+FA++ R A+A IGYPC+VKPVMSSSGKGQ+ +RS + AW YA Sbjct: 127 ETLGLATSPYQFAETLEELRAAIAKIGYPCLVKPVMSSSGKGQSTLRSEADVEAAWNYAA 186 Query: 183 QGGRAGAGRVIVEGVVKFDFEITLLTVSAVDG-----VHFCAPVGHRQEDGDYRESWQPQ 237 GGR +G+VIVEG + FD+EITLLTV AV +FC P+GH Q GDY ESWQPQ Sbjct: 187 SGGRVNSGKVIVEGFIDFDYEITLLTVRAVGASGQVETYFCDPIGHVQVKGDYVESWQPQ 246 Query: 238 QMSPLALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDL 297 MSP AL+ A++IA KV LGG GLFGVELFV GD+V FSEVSPRPHDTG+VTL+SQ Sbjct: 247 AMSPAALQSARDIAAKVTGDLGGRGLFGVELFVKGDKVWFSEVSPRPHDTGLVTLMSQRF 306 Query: 298 SEFALHVRAFLGLPVG-GIRQYGPAASAVILPQLTSQNVTFDNVQNAVGAD-LQIRLFGK 355 SEF LH RA LGLPV G+R+ P ASAVI + + F+ V+ A+ + +RLFGK Sbjct: 307 SEFELHARAILGLPVDTGMRE--PGASAVIYGGMNETGIAFEGVKEALSLPRIDLRLFGK 364 Query: 356 PEIDGSRRLGVALATAESVVDAIERAKHAAGQVK 389 PE RR+GVALA + A ERAKHAA V+ Sbjct: 365 PEAFERRRMGVALAAGDDTGIARERAKHAASLVR 398 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 474 Number of extensions: 18 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 408 Length adjustment: 31 Effective length of query: 361 Effective length of database: 377 Effective search space: 136097 Effective search space used: 136097 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory